RPHM / Reneo Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Reneo 製藥公司
US ˙ NasdaqGM ˙ US75974E1038
該符號不再有效

內部人士股份27,213,159 shares
內部人士情緒分數

「內部人士情緒分數」用於查找被公司內部人士購入的公司。

它是一個複雜的多因素量化模型的結果,該模型能夠辨識具有最高內部人士累積持有水平的公司。該評分模型結合了內部人士在過去90天內購買的淨數量、總購買股份佔流通股比例,以及內部人士擁有的總股份的指標。該分數的範圍從0到100,數值越高表示相對於同行業而言具有更高程度的內部人士持股水平,50為平均值。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

高管情緒分數

「高管情緒分數」用於查找被公司管理層購入的公司。

根據定義,公司高管是公司內部人士,但與其他內部人士(10%的股東和董事會成員)不同,公司高管每天在公司工作,而且他們使用自己的資金進行交易。(10%的股東和董事會成員通常是基金經理,管理著其他人的資金。)因此,公司高管進行的內幕交易更為重要性,應該被適當地重視和關注。

如同「內部人士情緒分數」,「高管情緒分數」也是一個複雜的多因素量化模型的計算結果,該模型能夠辨識具有最高高管累積持有水平的公司。

更新頻率:每日

查閱「內部人士首選」,該清單呈現被內部人士購入最多的公司。

關鍵內部人士指標

此表格顯示了公司在各種內部人士指標上的排名。百分位數排名顯示了這家公司在美國市場與其他公司相比的表現。排名越高表明公司所處狀況越好。

舉例來說,一般認為內部人士的買入是一個積極的指標,因此具有更多內部人士買入的公司將排名高於那些內部人士買入較少(甚至有內部人士賣出)的公司。

內部人士買入淨數(排名)

N/A

內部人士買入淨數是過去90天內買入的內部人士總數減去賣出的內部人士總數。以百分位排名顯示(範圍從0到100%)。

內部人士買入佔流通股比例(排名)

N/A

內部人士買入佔流通股比例是內部人士在過去90天內購買的股份總數減去賣出的股份總數,除以總流通股數並乘以100。

內幕交易圖表

以下圖表顯示了Reneo Pharmaceuticals, Inc.內部人士交易。內部人士包括公司的高管、董事或重要投資者。一般而言,基於內幕、非公開信息進行交易是非法的。這並不意味著他們在自己的公司進行任何交易都是非法的。但是,他們必須透過Form 4向美國證券交易委員會(SEC)報告所有交易。

內部人員名單及盈利指標

這張表格顯示已知的內部人員名單,從向SEC披露的申報文件中自動生成。除了姓名、最近的職稱和董事、高管或10%擁有人的標誌外,我們還提供了最新披露的持股信息。此外,我們盡可能提供內部人的歷史交易表現。歷史交易表現是內部人士實際進行的公開市場購買交易表現的加權平均值。有關此計算方式的更多資訊,請查看YouTube網絡研討會

See our leaderboard of most profitable insider traders.

內部人士 平均收益(%) 持股
數量
分拆
調整

Report errors via our new Insider Auditing Tool

追蹤內部人士買入記錄 - 短期收益分析

在這一部分,我們分析了在 RPHM / Reneo Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士購買的盈利情況。這種分析有助於了解內部人士是否持續產生異常的回報,以及是否值得跟踪。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最高利潤的
天數
達到最高利潤時的
價格
最高
淨利 ($)
最高回報率(%)
2025-05-15 ACORN BIOVENTURES, L.P. 270,270 1.8500 270,270 1.8500 500,000 0
2025-05-15 ACORN BIOVENTURES, L.P. 1,129,730 1.8500 1,129,730 1.8500 2,090,000
2024-09-25 Leonard Braden Michael 68,746 1.4964 68,746 1.4964 102,872
2024-09-24 Leonard Braden Michael 29,600 1.4144 29,600 1.4144 41,866
2024-09-18 Leonard Braden Michael 806 1.4000 806 1.4000 1,128
2024-09-17 Leonard Braden Michael 55,300 1.3582 55,300 1.3582 75,108
2024-09-16 Leonard Braden Michael 172,747 1.3712 172,747 1.3712 236,871
2024-09-13 Leonard Braden Michael 150,000 1.3130 150,000 1.3130 196,950
2024-09-12 Leonard Braden Michael 36,176 1.3966 36,176 1.3966 50,523

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

RPHM / Reneo Pharmaceuticals, Inc. Insider Trades
追蹤內部人士賣出記錄 - 短期虧損分析

在這一部分,我們分析了在 RPHM / Reneo Pharmaceuticals, Inc. 中進行的每筆非計劃的公開市場內部人士賣出所達成的短期虧損規避。如果存在持續的虧損規避模式,可能表明未來的內部人士賣出交易預示著價格的下跌。該分析基於每筆交易後一年的情況, 結果僅為理論值。 .

以下表格顯示了最近的自動交易計劃之外的公開市場購買。

交易日期 內部人士 報告
股數
報告
價格
經調整
股數
經調整
價格
成本基礎 達到最低利潤的
天數
達到最低利潤時的
價格
避免的
最高損失金額($)
避免的
最高損失率($)
2026-03-23 Saccomano Nicholas A 86 4.1565 86 4.1565 357 0
2026-03-23 Leverone Jason A. 301 4.1565 301 4.1565 1,251
2025-12-22 Leverone Jason A. 302 2.9677 302 2.9677 896
2025-12-22 Saccomano Nicholas A 87 2.9677 87 2.9677 258
2025-09-22 Leverone Jason A. 303 2.6235 303 2.6235 795
2025-09-22 Saccomano Nicholas A 88 2.6235 88 2.6235 231
2025-06-23 Leverone Jason A. 303 2.3842 303 2.3842 722
2025-06-23 Saccomano Nicholas A 88 2.3842 88 2.3842 210
2025-05-15 Cormorant Asset Management, LLC 1,813,439 1.8545 1,813,439 1.8545 3,363,023

經調整價格 已按拆股調整。 經調整股數 已按拆股調整。

RPHM / Reneo Pharmaceuticals, Inc. Insider Trades
交易歷史

點擊連結圖示即可查看完整的交易記錄。作為 10b5-1 自動交易計畫的一部分進行報告的交易,將在標記為 10b-5 的欄位中顯示 X。

呈報
日期
交易
日期
表格 內部人士 證券代碼 證券種類 代碼 10b5-1 直接 行使
價格
單位
價格
股數
變化
價值
變化 (1K)
剩餘
期權
剩餘
股份
2026-04-07 3 AI Biotechnology LLC OKUR Class A Common Stock D 3,998,332
2026-03-24 2026-03-23 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 4.1565 -301 -1 16,000
2026-03-24 2026-03-23 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 4.1565 -86 -0 7,333
2026-01-02 2025-12-31 4 Mathers Edward T OKUR Class A Common Stock A - Award D 3,911 15,310
2026-01-02 2025-12-31 4 Manke Isaac OKUR Class A Common Stock A - Award D 5,258 20,583
2025-12-23 2025-12-22 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 2.9677 -87 -0 7,419
2025-12-23 2025-12-22 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 2.9677 -302 -1 16,301
2025-10-02 2025-09-30 4 Mathers Edward T OKUR Class A Common Stock A - Award D 4,125 11,399
2025-10-02 2025-09-30 4 Manke Isaac OKUR Class A Common Stock A - Award D 5,545 15,325
2025-09-24 2025-09-22 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 2.6235 -88 -0 3,506
2025-09-24 2025-09-22 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 2.6235 -303 -1 12,603
2025-07-02 2025-06-30 4 Mathers Edward T OKUR Class A Common Stock A - Award D 4,694 7,274
2025-07-02 2025-06-30 4 Manke Isaac OKUR Class A Common Stock A - Award D 6,311 9,780
2025-06-25 2025-06-23 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 2.3842 -88 -0 3,594
2025-06-25 2025-06-23 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 2.3842 -303 -1 12,906
2025-05-27 3 Acorn Capital Advisors GP 2, LLC OKUR Common Stock D 1,129,730
2025-05-19 2025-05-15 4 ACORN BIOVENTURES, L.P. By Acorn Bioventures 2, L.P. OKUR Common Stock P - Purchase I 1.8500 1,129,730 2,090 1,129,730
2025-05-19 2025-05-15 4 ACORN BIOVENTURES, L.P. OKUR Common Stock P - Purchase D 1.8500 270,270 500 1,709,944
2025-05-19 2025-05-15 4 Cormorant Asset Management, LLC OKUR Class A Common Stock S - Sale I 1.8545 -1,813,439 -3,363 0
2025-05-14 2025-05-12 4 Cormorant Asset Management, LLC See Footnotes OKUR Class A Common Stock S - Sale I 1.9850 -24,300 -48 1,813,439
2025-04-08 2025-04-07 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 2.6710 -516 -1 3,682
2025-04-08 2025-04-04 4 Saccomano Nicholas A OKUR Class A Common Stock S - Sale D 3.3276 -358 -1 4,198
2025-04-08 2025-04-07 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 2.6710 -1,844 -5 13,209
2025-04-08 2025-04-04 4 Leverone Jason A. OKUR Class A Common Stock S - Sale D 3.3276 -1,278 -4 15,053
2025-04-02 2025-03-31 4 Mathers Edward T OKUR Class A Common Stock A - Award D 2,580 2,580
2025-04-02 2025-03-31 4 Manke Isaac OKUR Class A Common Stock A - Award D 3,469 3,469
2024-10-15 3 Cormorant Asset Management, LLC See Footnotes OKUR Class A Common Stock I 1,837,739
2024-10-09 3 ACORN BIOVENTURES, L.P. OKUR Class A Common Stock D 1,439,674
2024-10-09 2024-10-07 4 Leonard Braden Michael OKUR Common Stock J - Other D 102,076 102,076
2024-10-09 2024-10-07 4 Leonard Braden Michael Holdings of BML Investment Partners, L.P. OKUR Common Stock J - Other I 345,739 345,739
2024-10-08 2024-10-04 4 Saccomano Nicholas A OKUR Class A Common Stock A - Award D 4,556 4,556
2024-10-08 2024-10-04 4 Leverone Jason A. OKUR Class A Common Stock A - Award D 16,331 16,331
2024-10-08 2024-10-04 4 Carruthers R Michael OKUR Class A Common Stock A - Award D 4,065 4,939
2024-10-08 2024-10-04 4 Carruthers R Michael OKUR Class A Common Stock A - Award D 874 874
2024-09-26 2024-09-25 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.4964 68,746 103 3,457,395
2024-09-26 2024-09-24 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.4144 29,600 42 3,388,649
2024-09-19 2024-09-18 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.4000 806 1 3,359,049
2024-09-19 2024-09-17 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.3582 55,300 75 3,358,243
2024-09-16 2024-09-16 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.3712 172,747 237 3,302,943
2024-09-16 2024-09-13 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.3130 150,000 197 3,130,196
2024-09-16 2024-09-12 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.3966 36,176 51 2,980,196
2024-08-14 2024-08-14 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.4132 100,487 142 2,944,020
2024-08-14 2024-08-13 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.3925 171,339 239 2,843,533
2024-05-16 2024-05-14 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.5400 335,000 516 2,672,194
2024-05-16 2024-05-14 4 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock P - Purchase I 1.5600 79,281 124 2,337,194
2024-05-16 3 Leonard Braden Michael RPHM Common Stock D 1,020,769
2024-05-16 3 Leonard Braden Michael Holding of BML Investment Partners, L.P. RPHM Common Stock I 2,672,194
2023-08-29 2023-08-28 4 Hall Ashley RPHM Common Stock S - Sale D 6.2757 -15,625 -98 39,600
2023-08-29 2023-08-28 4 Hall Ashley RPHM Common Stock M - Exercise D 1.8000 15,625 28 55,225
2023-07-27 2023-07-26 4 GREY MICHAEL G RPHM Common Stock G - Gift D -50,000 0
2023-06-23 2023-06-23 4 Novo A/S RPHM Common Stock S - Sale D 7.0974 -100,000 -710 3,330,337
2023-05-10 2023-05-08 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Common Stock P - Purchase I 8.0000 125,000 1,000 2,188,713
2022-12-13 2022-08-12 4 Dorenbaum Alejandro RPHM Common Stock G - Gift D -22,348 30,000
2022-09-02 2022-09-01 4 Cruse Michael by Trust RPHM Common Stock P - Purchase I 3.3930 7,500 25 13,697
2022-09-02 2022-08-31 4 GREY MICHAEL G RPHM Common Stock M - Exercise D 1.9700 50,000 98 50,000
2022-08-31 2022-08-31 4 Cruse Michael by Trust RPHM Common Stock P - Purchase I 3.2090 3,212 10 6,197
2022-08-31 2022-08-30 4 Cruse Michael by Trust RPHM Common Stock P - Purchase I 3.1938 1,845 6 2,985
2022-08-31 2022-08-30 4 Cruse Michael RPHM Common Stock P - Purchase D 3.1600 975 3 31,758
2022-08-31 2022-08-29 4 Cruse Michael by Trust RPHM Common Stock P - Purchase I 3.2400 1,140 4 1,140
2022-08-31 2022-08-29 4 Cruse Michael RPHM Common Stock P - Purchase D 3.2400 83 0 30,783
2022-04-05 3 Lam Jennifer RPHM Common Stock D 15,000
2022-03-04 2022-03-02 4 Cruse Michael RPHM Stock option (right to buy) A - Award D 4.58 25,000 25,000
2022-01-24 2022-01-20 4 Hoelscher Paul W. RPHM Stock Option (right to buy) A - Award D 8.01 35,000 35,000
2021-12-14 2021-12-10 4 Jindal Vineet R. RPHM Stock option (right to buy) A - Award D 6.69 100,000 100,000
2021-12-14 2021-12-10 4 Jindal Vineet R. RPHM Common Stock A - Award D 30,000 36,600
2021-12-14 2021-12-10 4 FLESHER GREGORY J. RPHM Stock option (right to buy) A - Award D 6.69 200,000 200,000
2021-12-14 2021-12-10 4 FLESHER GREGORY J. RPHM Common Stock A - Award D 100,000 109,600
2021-12-14 2021-12-10 4 Dorenbaum Alejandro RPHM Stock option (right to buy) A - Award D 6.69 100,000 100,000
2021-12-14 2021-12-10 4 Dorenbaum Alejandro RPHM Common Stock A - Award D 30,000 52,348
2021-12-14 2021-12-10 4 Cruse Michael RPHM Stock option (right to buy) A - Award D 6.69 75,000 75,000
2021-12-14 2021-12-10 4 Cruse Michael RPHM Common Stock A - Award D 25,000 29,100
2021-11-15 2021-11-12 4 Hall Ashley RPHM Stock Option (right to buy) A - Award D 8.85 180,000 180,000
2021-11-15 2021-11-12 4 Hall Ashley RPHM Common Stock A - Award D 30,000 30,000
2021-08-26 2021-08-25 4 Jindal Vineet R. RPHM Common Stock P - Purchase D 7.4353 5,000 37 5,000
2021-08-26 2021-08-25 4 FLESHER GREGORY J. RPHM Common Stock P - Purchase D 8.0000 8,000 64 8,000
2021-08-26 2021-08-25 4 Cruse Michael RPHM Common Stock P - Purchase D 7.4464 2,500 19 2,500
2021-07-15 2021-07-14 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 8.5000 111,736 950 2,073,957
2021-07-15 2021-07-14 4 Johnson Wendy S. RPHM Common Stock S - Sale D 8.5000 -111,736 -950 0
2021-07-09 2021-07-08 4 Johnson Wendy S. RPHM Stock option (right to buy) M - Exercise D 1.97 -111,736 0
2021-07-09 2021-07-08 4 Johnson Wendy S. RPHM Common Stock M - Exercise D 1.9700 111,736 220 111,736
2021-06-25 2021-06-23 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.2827 20,710 192 1,962,221
2021-06-23 2021-06-22 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 8.7230 14,615 127 1,941,511
2021-06-23 2021-06-21 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.0305 32,659 295 1,926,896
2021-06-10 2021-06-08 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.4977 16,605 158 1,894,237
2021-06-07 2021-06-04 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.4242 257 2 1,877,632
2021-06-07 2021-06-03 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.2515 12,100 112 1,877,375
2021-06-02 2021-05-28 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.5000 14 0 1,865,275
2021-05-28 2021-05-27 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.2583 1,120 10 1,865,261
2021-05-28 2021-05-26 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 9.3821 5,915 55 1,864,141
2021-04-15 2021-04-13 4 New Enterprise Associates 15, L.P. RPHM Series B Preferred Stock C - Conversion D -8,904,280 0
2021-04-15 2021-04-13 4 New Enterprise Associates 15, L.P. RPHM Series A Preferred Stock C - Conversion D -9,526,652 0
2021-04-15 2021-04-13 4 New Enterprise Associates 15, L.P. RPHM Common Stock P - Purchase D 15.0000 666,666 10,000 4,785,494
2021-04-15 2021-04-13 4 New Enterprise Associates 15, L.P. RPHM Common Stock C - Conversion D 1,989,872 4,118,828
2021-04-15 2021-04-13 4 New Enterprise Associates 15, L.P. RPHM Common Stock C - Conversion D 2,128,956 2,128,956
2021-04-15 2021-04-13 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Series B Preferred Stock C - Conversion I -3,710,116 0
2021-04-15 2021-04-13 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Series A Preferred Stock C - Conversion I -4,629,630 0
2021-04-15 2021-04-13 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Common Stock P - Purchase I 15.0000 200,000 3,000 2,063,713
2021-04-15 2021-04-13 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Common Stock C - Conversion I 829,113 1,863,713
2021-04-15 2021-04-13 4 O'Donnell Niall By RiverVest Venture Fund IV, L.P. RPHM Common Stock C - Conversion I 1,034,600 1,034,600
2021-04-15 2021-04-13 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Series B Preferred Stock C - Conversion I -7,420,232 0
2021-04-15 2021-04-13 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock P - Purchase I 15.0000 200,000 3,000 1,858,226
2021-04-15 2021-04-13 4 Muralidhar Bali By Abingworth Bioventures 8 LP RPHM Common Stock C - Conversion I 1,658,226 1,658,226
2021-04-15 3/A GREY MICHAEL G RPHM Common Stock I 424,600
2021-04-15 2021-04-13 4 GREY MICHAEL G RPHM Series A Preferred Stock C - Conversion I -90,222 0
2021-04-15 2021-04-13 4 GREY MICHAEL G RPHM Common Stock C - Conversion I 20,162 444,762
2021-04-14 2021-04-13 4 Novo A/S RPHM SERIES B CONVERTIBLE PREFERRED STOCK C - Conversion D -12,367,054 0
2021-04-14 2021-04-13 4 Novo A/S RPHM COMMON STOCK P - Purchase D 15.0000 666,666 10,000 3,430,377
2021-04-14 2021-04-13 4 Novo A/S RPHM COMMON STOCK C - Conversion D 2,763,711 2,763,711
2021-04-13 2021-04-09 4 RiverVest Venture Fund III, L.P. RPHM Series B Preferred Stock C - Conversion I -3,710,116 0
2021-04-13 2021-04-09 4 RiverVest Venture Fund III, L.P. RPHM Series A Preferred Stock C - Conversion I -4,925,711 0
2021-04-13 2021-04-09 4 RiverVest Venture Fund III, L.P. RPHM Common Stock P - Purchase I 15.0000 200,000 3,000 2,409,220
2021-04-13 2021-04-09 4 RiverVest Venture Fund III, L.P. RPHM Common Stock C - Conversion I 829,113 2,209,220
2021-04-13 2021-04-09 4 RiverVest Venture Fund III, L.P. RPHM Common Stock C - Conversion I 1,100,765 1,380,107
2021-04-12 2021-04-08 4 Cardon Lon RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 Harrison Kenneth Ph.D. RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 Seltzer Stacey Denenberg RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 GREY MICHAEL G RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 O'Donnell Niall RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 Muralidhar Bali RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-12 2021-04-08 4 Mathers Edward T RPHM Stock Option (right to buy) A - Award D 15.00 14,000 14,000
2021-04-08 3 RiverVest Venture Fund IV, L.P. RPHM Common Stock I 279,342
2021-04-08 3 GREY MICHAEL G RPHM Common Stock I 134,084
2021-04-08 3 GREY MICHAEL G RPHM Common Stock I 424,601
2021-04-08 3 Dorenbaum Alejandro RPHM Common Stock D 22,348
P
非衍生或衍生證券的公開市場或私下買入
S
非衍生或衍生證券的公開市場或私下賣出
A
公司向內部人員授予、獎勵或以其他方式獲取證券(例如股票期權)
C
衍生工具轉換
D
將證券賣出或轉讓回公司
F
使用從公司收到的證券的一部分來支付行使價或稅務負擔。
G
內部人士贈送或接收他人贈送公司股票
K
股權掉期和類似的避險交易
M
行使或轉換從公司獲得的衍生證券(例如期權)
V
內部人士透過Form 4自願報告的一筆交易
J
其他(附有交易描述的腳註)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista